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There are few reported cases of colorectal metastasis from cancers of other organs, particularly other segments
of the colon. Here we describe the long-term survival of a 68-year-old male patient with metachronous rectal
metastasis from cecal cancer who underwent repetitive resection and chemotherapy. The patient underwent
ileocecal resection and hepatectomy for cecal cancer with liver metastasis (T3, N1a, M1a, Stage IVA) in 2006.
The patient subsequently underwent splenectomy for splenic metastasis in 2007. In August 2008, barium
enema revealed compression of the rectal wall, and abdominal computed tomography (CT) detected a mass
along the rectum extending into the pelvis. Rectal metastasis from cecal cancer was suspected and Hartmann’s
operation with bilateral seminal vesicle dissection was performed. Histological examination of the excised
tumor revealed moderately differentiated adenocarcinoma formed in the muscularis propria of the rectum
and infiltrating the connective tissue between the seminal vesicle and rectum. However, no tumor was
detected in the rectal mucosa or submucosa. These histological findings supported the diagnosis of rectal
metastasis from cecal cancer. The patient has been monitored at our clinic for 60 months after surgical
removal of the rectal metastasis. The findings from this case should alert oncologists to the potential danger
of rectal metastasis from primary colon cancer and the benefits of timely complete resection in terms of
improved patient outcomes.
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Timely detection and improved treatment of metasta-
tic disease have dramatically increased the long-term
survival of many cancer patients. Although colorec-
tal cancer is one of the most common neoplasias, it
rarely arises as metastasis from cancer in other seg-
ments of the colon. There is no consensus regarding
the most effective treatment strategy for such cases.
Here we report the long-term survival of a 68-year-
old male patient with metachronous rectal metastasis
from cecal cancer who underwent repetitive resection
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A 68-year-old male patient presented at the Depart-
ment of Gastrointestinal Surgery (Ibaraki Medical Center,
Ami, Japan) with progressive abdominal distention and
narrowing of the feces for 2 months. The patient’s medical
history revealed that he had undergone ileocecal resection
for cecal cancer with solitary liver metastasis in September
2006. Light microscopy of the resected specimen revealed
moderately differentiated adenocarcinoma infiltrating the
deep layers through the muscularis propria of the cecum
and metastases in 1 of 14 lymph nodes. The tumor was di-
agnosed as stage IVA (T3, N1a, M1a) according to the
International Union Against Cancer tumor, node, and me-
tastasis (TNM) classification (7th edition) [1]. After oral
tegafur/uracil and oral leucovorin combination chemo-
therapy for 3 months, the solitary liver metastasis wasral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Barium enema reveals compression of the rectal wall
and a partially uneven mucosal surface (arrow).
Figure 2 Abdominal computed tomography (CT) reveals a mass meas
into the pelvis (arrow).
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patient subsequently underwent splenectomy for splenic
metastasis in 2007.
The findings of subsequent physical examination were
unremarkable except for slight pallor in the palpebral
conjunctiva. Hematological investigation revealed ane-
mia (hemoglobin, 10.6 g/dl; hematocrit, 31.4%), while
other laboratory test results and serum levels of carci-
noembryonic antigen and carbohydrate antigen 19-9 were
within normal limits. Barium enema revealed compression
of the rectal wall with a partially uneven mucosal surface
(Figure 1), and colonoscopy revealed slight mucosal ery-
thema at the rectum. No tumor was detected in mucosal
biopsy specimens; however, abdominal computed tomog-
raphy (CT) revealed a pelvic mass measuring 40 mm in
diameter along the rectum (Figure 2). We suspected rectal
metastasis from cecal cancer and performed Hartmann’s
operation with bilateral seminal vesicle dissection in
August 2008.
The mass had penetrated the anterior wall of the rectum
below the peritoneal reflection. There were no intraope-
rative findings of disseminated tumor in the abdominal
cavity, findings inconsistent with disseminated perito-
neal metastasis. The resected tumor measured 5.5 × 4.0 ×
3.5 cm and had an uneven surface (Figure 3). Sections of
the tumor revealed solid gray, yellowish myxoid areas.
Histological examination of the excised tumor showed
moderately differentiated adenocarcinoma formed in the
muscularis propria of the rectum and infiltrating the con-
nective tissue between the seminal vesicle and rectum
(Figure 4A,B). However, no tumor was apparent in the
rectal mucosa or submucosa. These findings supporteduring 40 mm in diameter along the rectal wall and extending
Figure 3 Macroscopic findings from the resected specimen.
The tumor is submucosal with an uneven mucosa and measures
5.5 × 4.0 × 3.5 cm.
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treated in September 2006.
Abdominal CT performed 6 months later in April 2009
revealed liver metastases, and the patient was treated with
fluorouracil, leucovorin, and oxaliplatin + bevacizumab
combination therapy. The patient exhibited complete ini-
tial clinical response; however, follow-up abdominal CT
revealed growth of the liver metastases. The patient
refused continued chemotherapy because of peripheral
neuropathy caused by oxaliplatin and subsequently un-
derwent partial hepatectomy in October 2011, pneumon-
ectomy for lung metastasis in April 2012, and partial
hepatectomy for liver metastasis in September 2012. Fol-
lowing the surgery to remove the rectal metastasis, the pa-
tient has been monitored at our outpatient clinic for
60 months.
Discussion
Cases of colorectal metastasis from cancers of other
organs have occasionally been reported [2-5], but colo-
rectal metastasis from other segments of the colon isFigure 4 Histological analysis of the resected specimen. (A) Moderate
of the rectum (H & E, 40×). (B) Tumor cells infiltrating the connective
hematoxylin and eosin.extremely rare. Nakamura et al. [6] and Kalaitzis et al.
[7] reported single cases of rectal metastasis from cancer
of the sigmoid colon, and this is the first report, as per
our knowledge, of rectal metastasis from cecal cancer. In
our patient, metachronous rectal metastasis originated
from cecal cancer resected 2 years back. We suspect a
hematogenous metastatic pathway for the following rea-
sons. First, the patient has a history of liver and splenic
metastasis from the cecal cancer, indicating systemic
hematogenous metastasis. Second, rectal metastasis was
present below the peritoneal reflection, and there was no
disseminated tumor in the abdominal cavity, ruling out
disseminated peritoneal metastasis. Third, tumor cells
proliferated mainly in the rectal wall, ruling out lymph
node metastasis.
The survival of patients with metastatic colorectal can-
cer has improved with combined therapies, including
chemotherapy [8]. However, there is no consensus strat-
egy for the diagnosis and treatment of metastasis from
other sites of primary colorectal cancer. Inada et al. [4]
reported that immunohistochemical staining is effective
for diagnosis. In the present case, however, preopera-
tive histological examinations with colonoscopy did not
detect rectal metastasis because the tumor was entirely
submucosal. We selected surgery to treat the rectal tu-
mor because preoperative histological examinations were
inconclusive and definitive histological diagnosis was re-
quired to establish treatment. It remains debatable whe-
ther resection of metastases from other sites of primary
colorectal cancer can improve outcome because no si-
milar report has been published. However, the Japanese
guidelines for the treatment of colorectal cancer recom-
mend surgery for metastatic lesions if the primary colo-
rectal lesion and metastases are completely resectable
and the performance status of the patient is acceptable
[9]. In the present case, rectal metastasis was the only
tumor detectable by preoperative examination; further-
more, the performance status of the patient was good.ly differentiated adenocarcinoma formed in the propria muscularis
tissue between the seminal vesicle and rectum (H & E, 200×). H & E,
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tributed to successful outcome in the present case.
The patient’s tumor metastasized to the liver and lung
after Hartmann’s operation. Fluorouracil, leucovorin, and
irinotecan + bevacizumab combination therapy was an
option for second-line therapy against the metastases
[10,11]; however, the patient refused additional chemo-
therapy because of intolerable side effects and opted for
surgery instead. The 5-year survival rates after hepatec-
tomy for liver metastasis and pneumonectomy for lung
metastasis from colorectal cancer are 35 to 58% and 30 to
68%, respectively [12-15]. Moreover, the overall survival of
patients with completely resectable lung metastases is bet-
ter than that of patients with unresectable lung metastases
[15,16]. The patient has been monitored for 5 years after
Hartmann’s operation, and repetitive resection and che-
motherapy for the metastases appear to have contributed
to long-term survival.
Conclusions
Colorectal metastasis from other sites of primary colon
cancer is extremely rare, and complete resection of these
metastatic lesions may significantly improve outcome.
The findings from this case should alert oncologists to the
potential danger of rectal metastasis from primary colon
cancer and the benefits of timely complete resection.
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